Erratum: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck (Clin Cancer Res (2021) 27 (4557–65) DOI: 10.1158/1078-0432.CCR-21-0585)

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), one patient's pathologic response was misclassified as partial instead of major. This error affects the data reported in Fig. 1A, in Supplementary Tables S3 and S4, and in the text of the Abstract, Results, and Discussion sections, but does not impact the primary endpoint. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

Original languageEnglish (US)
Pages (from-to)1735
Number of pages1
JournalClinical Cancer Research
Volume28
Issue number8
DOIs
StatePublished - Apr 15 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

MD Anderson CCSG core facilities

  • Biostatistics Resource Group

Fingerprint

Dive into the research topics of 'Erratum: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck (Clin Cancer Res (2021) 27 (4557–65) DOI: 10.1158/1078-0432.CCR-21-0585)'. Together they form a unique fingerprint.

Cite this